Finance

Lists
CWK:NYSE
Cushman & Wakefield Ltd
$11.39
-1.43%
(-0.16) 1D
$11.39
0.00% (0.00)
After hours
Closed: Oct 13, 4:00:07 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CWK...
Open
$11.60
High
$11.63
Low
$11.18
Mkt. cap
2.67B
Avg. vol.
2.36M
Volume
3.49M
P/E ratio
39.27
52-wk high
$17.40
52-wk low
$11.15
EPS
$0.29
Beta
1.50
Shares outstanding
234.71M
No. of employees
53K
Open
$11.60
High
$11.63
Low
$11.18
Mkt. cap
2.67B
Avg. vol.
2.36M
Volume
3.49M
P/E ratio
39.27
52-wk high
$17.40
52-wk low
$11.15
EPS
$0.29
Beta
1.50
Shares outstanding
234.71M
No. of employees
53K
News stories
From web sources and news partners
About Cushman & Wakefield Ltd
CEO-
Employees53K
Founded1784
Headquarters-
Sector-
Websitecushmanwakefield.com
Analyst ratings
Based on 6 analysts giving stock ratings to CWK in the past 3 months
Buy
Buy
3
Hold
3
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for CWK in the last 3 months.
Highest
Current $11.39
$19.00 (+66.81%)
Average
$17.20 (+51.01%)
Lowest
$15.00 (+31.69%)
Analyst
Recommendation
Action
Price target
Projected
Date
Anthony Paolone
J.P. Morgan
Hold
Maintained
$17.00
+49.3%
10/13/2026
Julien Blouin
Goldman Sachs
Buy
Maintained
$19.00
+66.8%
08/18/2026
Brendan Lynch
Barclays
Hold
Maintained
$16.00
+40.5%
08/17/2026
Alex Kramm
UBS
Hold
Maintained
$15.00
+31.7%
08/10/2026
Ronald Kamdem
Morgan Stanley
Buy
Maintained
$19.00
+66.8%
08/05/2026
Stephen Sheldon
William Blair
Buy
Maintained
-
-
08/05/2026
Unknown Analyst
J.P. Morgan
Hold
Maintained
$20.00
+75.6%
03/30/2026
Andrew Rosivach CFA
Wolfe Research
Buy
Upgraded
$19.00
+66.8%
02/08/2026
Last report
Aug 5, 2026
Fiscal period
Q2 2026
$0.35 / $0.35
+0.87%beat
Revenue / Est. (USD)
2.76B / 2.65B
+4.19%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
2.61B
2.91B
2.54B
2.76B
Cost of goods sold
2.15B
2.34B
2.12B
2.25B
Cost of revenue
2.15B
2.34B
2.12B
2.25B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
320.60M
372.90M
336.80M
349.30M
Operating expense
346.40M
398.40M
362.10M
377.80M
Total operating expenses
2.50B
2.74B
2.48B
2.63B
Operating income
107.50M
176.10M
58.60M
134.20M
Other non operating income
2.50M
10.30M
-13.90M
4.10M
EBT including unusual items
45.10M
-12.10M
-9.60M
77.30M
EBT excluding unusual items
45.40M
-35.80M
-8.60M
83.00M
Income tax expense
-6.30M
10.30M
3.00M
24.60M
Effective tax rate
-13.97%
-85.12%
-31.25%
31.82%
Other operating expenses
-
-
-
-
Net income
51.40M
-22.40M
-12.60M
52.70M
Net profit margin
1.97%
-0.77%
-0.50%
1.91%
Earnings per share
0.29
0.54
0.15
0.35
Interest and investment income
-
-
-
-
Interest expense
-56.00M
-51.20M
-49.20M
-57.60M
Net interest expenses
-56.00M
-51.20M
-49.20M
-57.60M
Depreciation and amortization charges
25.80M
25.50M
25.30M
28.50M
EBITDA
133.30M
201.60M
83.90M
162.70M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps